title: ADPKD: clinical issues before and after renal transplantation.
abstract: Autosomal dominant polycystic kidney disease (ADPKD) is the first genetic cause of end-stage renal disease (ESRD) and the number of these patients who are listed for or receive a kidney transplant (KTx) is continuously increasing over time. Hence, nephrologists are involved not only in the handling of ADPKD patients during the long course of the disease, but also in programming and performing a renal transplant. The handling of all these processes implies the complete awareness of a number of critical points related to the decisions to be taken both before and after the transplant intervention. In the present review, we will briefly deal with the main critical points related to the clinical handling of the patients both before and after KTx.
authors.affiliation: Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico di Milano, Università agli studi di Milano, Area Omogenea Nefro-Urologica e Trapianto di Rene, Milan, Italy. pmessa@policlinico.mi.it.|Unità di Nefrologia e Dialisi, Università agli studi di Milano, Milan, Italy. pmessa@policlinico.mi.it.
authors.forename: Piergiorgio
authors.identifier: http://orcid.org/0000-0002-1512-559X
authors.initials: P
authors.lastname: Messa
authors.affiliation: Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico di Milano, Università agli studi di Milano, Area Omogenea Nefro-Urologica e Trapianto di Rene, Milan, Italy.|Unità di Nefrologia e Dialisi, Università agli studi di Milano, Milan, Italy.
authors.forename: Carlo Maria
authors.initials: CM
authors.lastname: Alfieri
authors.affiliation: Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico di Milano, Università agli studi di Milano, Area Omogenea Nefro-Urologica e Trapianto di Rene, Milan, Italy.|Unità di Urologia, Università agli studi di Milano, Milan, Italy.
authors.forename: Emanuele
authors.initials: E
authors.lastname: Montanari
authors.affiliation: Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico di Milano, Università agli studi di Milano, Area Omogenea Nefro-Urologica e Trapianto di Rene, Milan, Italy.|Unità Chirurgia del Trapianto di Rene, Università agli studi di Milano, Milan, Italy.
authors.forename: Mariano
authors.initials: M
authors.lastname: Ferraresso
authors.affiliation: Fondazione Ca' Granda IRCCS Ospedale Maggiore Policlinico di Milano, Università agli studi di Milano, Area Omogenea Nefro-Urologica e Trapianto di Rene, Milan, Italy.|Unità di Nefrologia e Dialisi, Università agli studi di Milano, Milan, Italy.
authors.forename: Roberta
authors.initials: R
authors.lastname: Cerutti
mesh_terms: D000066491:Clinical Decision-Making; D018450:Disease Progression; D006085:Graft Survival; D006801:Humans; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000235:genetics / Q000601:surgery*; D016030:Kidney Transplantation / Q000009:adverse effects; D000072104:Nephrologists; D018579:Patient Selection; D016891:Polycystic Kidney, Autosomal Dominant / Q000150:complications / Q000175:diagnosis / Q000235:genetics / Q000601:surgery*; D011183:Postoperative Complications / Q000209:etiology; D024382:Professional Role; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome